118 related articles for article (PubMed ID: 16635113)
1. Facilitation action of N-acetylcysteine on the anticonvulsant effect of sodium valproate in mice.
Devi PU; Pillai KK; Vohora D
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):521-2. PubMed ID: 16635113
[No Abstract] [Full Text] [Related]
2. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Mohamed M; Czuczwar SJ
Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
[TBL] [Abstract][Full Text] [Related]
3. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
4. Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine.
Uma Devi P; Pillai KK; Vohora D
Fundam Clin Pharmacol; 2006 Jun; 20(3):247-53. PubMed ID: 16671959
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study.
Luszczki JJ; Wojda E; Andres-Mach M; Cisowski W; Glensk M; Glowniak K; Czuczwar SJ
Epilepsy Res; 2009 Aug; 85(2-3):293-9. PubMed ID: 19406619
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacologic modulation of the anticonvulsant action of calcium-valproate in maximal electroshock in the mouse].
Fischer W
Pharmazie; 1989 May; 44(5):356-7. PubMed ID: 2505279
[No Abstract] [Full Text] [Related]
7. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock.
Borowicz KK; Morawska M; Furmanek-Karwowska K; Luszczki JJ; Czuczwar SJ
Eur J Pharmacol; 2007 Nov; 573(1-3):111-5. PubMed ID: 17643415
[TBL] [Abstract][Full Text] [Related]
8. N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Kocharov SL; Czuczwar SJ
Neurosci Res; 2009 Jul; 64(3):267-72. PubMed ID: 19447295
[TBL] [Abstract][Full Text] [Related]
9. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice.
Luszczki JJ; Glowniak K; Czuczwar SJ
Eur J Pharmacol; 2007 Nov; 574(2-3):133-9. PubMed ID: 17651727
[TBL] [Abstract][Full Text] [Related]
10. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats.
Sobaniec W; Sobaniec-Lotowska M
Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038
[TBL] [Abstract][Full Text] [Related]
11. [The comparative action of calcium valproate (Convulsofin) with sodium valproate and free acid].
Morgenstern E; Stattmann A; Dove B; Göres E
Pharmazie; 1984 Dec; 39(12):870-1. PubMed ID: 6442425
[No Abstract] [Full Text] [Related]
12. Synergistic effect of flunarizine and sodium valproate on seizure thresholds elicited by cortical stimulation in conscious rats.
Joseph S; David J; Joseph T
Indian J Physiol Pharmacol; 1998 Jan; 42(1):39-49. PubMed ID: 9513792
[TBL] [Abstract][Full Text] [Related]
13. [Anticonvulsant and neurotoxic effects of various combinations of phenobarbital, diazepam, sodium valproate, and 1,4-dihydropyridine ryodipine].
Karpova MN; Kryzhanovskiĭ GN; Abrosimov IIu
Biull Eksp Biol Med; 1994 Jul; 118(7):14-6. PubMed ID: 7919262
[No Abstract] [Full Text] [Related]
14. The influence of memantine on the anticonvulsant effects of the antiepileptic drugs.
Chojnacka-Wójcik E; Tatarczyńska E; Maj J
Pol J Pharmacol Pharm; 1983; 35(6):511-5. PubMed ID: 6429651
[TBL] [Abstract][Full Text] [Related]
15. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model.
Luszczki JJ; Sawicka KM; Kozinska J; Borowicz KK; Czuczwar SJ
Epilepsy Res; 2007 Aug; 76(1):66-72. PubMed ID: 17659862
[TBL] [Abstract][Full Text] [Related]
16. The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity.
Kerwin RW; Olpe HR; Schmutz M
Br J Pharmacol; 1980; 71(2):545-51. PubMed ID: 6781578
[TBL] [Abstract][Full Text] [Related]
17. Prevention of sodium valproate-induced hepatotoxicity by curcumin, rosiglitazone and N-acetylcysteine in rats.
Said SA; El-Agamy DS
Arzneimittelforschung; 2010; 60(11):647-53. PubMed ID: 21175036
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and pharmacological evaluation of alpha-substituted N-benzylamides of gamma-hydroxybutyric acid with potential GABA-ergic activity. Part 6. Search for new anticonvulsant compounds.
Malawska B; Kulig K; Gajda J; Szczeblewski D; Musiał A; Wieckowski K; Maciag D; Stables JP
Acta Pol Pharm; 2007; 64(2):127-37. PubMed ID: 17665862
[TBL] [Abstract][Full Text] [Related]
19. Influence of sodium valproate and carbamazepine on GSH levels in rat cerebral cortex.
Attaguile G; Caruso A; Cutuli VM; Di Giacomo C; Russo A; De Bernardis E; Amico-Roxas M
Drugs Exp Clin Res; 1992; 18(11-12):465-7. PubMed ID: 1308471
[TBL] [Abstract][Full Text] [Related]
20. [Anticonvulsant and neurotoxic effects of lamiktal (lamotrigine) in combination with other anticonvulsants].
Karpova MN; Abrosimov IIu; Kryzhanovskiĭ GN; Raevskiĭ KS
Biull Eksp Biol Med; 1997 Aug; 124(8):141-3. PubMed ID: 9410193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
